Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination antibiotic regimen investigated for the treatment of chronic periodontitis. It consists of locally delivered tetracycline (administered directly into periodontal pockets) combined with systemically administered amoxicillin and metronidazole. This triple-antibiotic approach is used as an adjunct to scaling and root planing (SRP) to target a broad spectrum of periodontal pathogens, including anaerobic and gram-negative bacteria like *Porphyromonas gingivalis* and *Aggregatibacter actinomycetemcomitans*. The regimen was evaluated in a Phase 3 clinical trial (NCT01098448) led by The Forsyth Institute to determine its efficacy in reducing pocket depth and improving clinical attachment levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tetracycline + metronidazole + amoxicillin.